About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study.

Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts.

com/ Position Purpose: We are seeking a Director, Technical Accounting and SEC Reporting. In this newly created position, which reports to the Vice President, Controller, you will oversee all aspects of the Company’s technical accounting, SOX controls and external reporting activities within a publicly traded environment. S.

GAAP and SEC regulations, leads the preparation and filing of all SEC reports, and provides authoritative guidance on complex accounting matters. The Director serves as a key advisor to executive leadership and plays a critical role in maintaining the integrity, transparency, and accuracy of the Company’s financial disclosures to investors, regulators, and external stakeholders.

Key Responsibilities

Requirements

, ActiveDisclosure, NetSuite) Exceptional written communication skills, particularly in drafting financial disclosures Proven ability to manage multiple deadlines in a highly regulated, fast-paced environment Strong analytical mindset and attention to detail Advanced Excel and financial analysis capabilities Location(s): Stoke operates in Bedford, MA.